Ind-Swift Laboratories Limited

Ind-Swift Laboratories Limited

INDSWFTLAB.NS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$28.48B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ind-Swift Laboratories LimitedInd-Swift Laboratories Limited48-4%5-
$12.73

Current Fair Value

96.6% downside

Overvalued by 96.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$28.48 Billion
Enterprise Value$28.48 Billion
Earnings per Share$4.95
Beta0.71
Outstanding Shares86,836,600

Return

Return on Equity4.14%ROE
Return on AssetsNaN%
Return on Invested CapitalNaN%

Valuation & Multiples

P/E Ratio48.01P/E Ratio
PEG26.48PEG
Price to Sales4.99Price to Sales
Price to Book Ratio2.38Price to Book Ratio
Enterprise Value to Revenue4.28
Enterprise Value to EBIT62.22
Enterprise Value to Net Income49
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Ind-Swift Laboratories Limited

1,388 employees
CEO: Navrattan R. Munjal

Established in 1995 and headquartered in Manimajra, India, Ind-Swift Laboratories Limited is an Indian pharmaceutical company primarily focused on the creation, production, and commercialization of active pharmaceutical ingredients (APIs...